Introduction
============

Higher organisms benefit from their microbiota, which offers nutritional and physiological advantages to the host in exchange for a nutrient-rich habitat. Microbes (bacteria, archaea, viruses, fungi, protozoans, etc.) reside on all mucosal surfaces of the body, with the gut harboring by far the most numerous population. Separating the microbial cells from the host is the intestinal barrier, which serves as an interface for many complex interactions. Two major components of the intestinal barrier are the intestinal epithelium and the gut associated lymphoid tissue (GALT). This tissue has the challenging dual task of selectively absorbing nutrients from the intestinal lumen, while preventing microbial entry and infection. The majority of microbes that reside in the intestine are commensals and do not pose a threat to the host under normal conditions. Thus, the host's immune system must learn to tolerate this enormous commensal antigenic load. One of the strategies that the host utilizes to avoid an inflammatory response against the microbiota is to remain "ignorant" to a portion of the microbial antigens, by using the intestinal barrier, including the mucous layer and immunoglobulin (Ig) A, to maintain these antigens at a distance to the mucosal surface (Hansson and Johansson, [@B18]; Hooper and Macpherson, [@B19]). However, it is now clear that there is also constant communication between microbial cells or signals and host cell receptors, and that many of these interactions lead to the development of immune tolerance toward bacterial antigens (Hooper and Macpherson, [@B19]; Geuking et al., [@B16]).

Traditionally, it has been accepted that the evolution of the mammalian immune system has been driven by selective pressures imposed by pathogenic bacteria (Matsunaga and Rahman, [@B27]). For example, the emergence of jaws in cartilaginous fish matches the appearance of antigen receptor specificity and immunological memory in B and T cells, as well as the major histocompatibility complexes (MHC) I and II, all characteristic of the adaptive immune system (Agrawal et al., [@B3]). Immunologists have speculated that the jaw gave organisms the ability to ingest harder food sources that could damage the gut mucosa, likely increasing their risk for infections. The nutritional advantages of having a jaw allowed organisms to augment their body size and life expectancy, increasing their risk for repeated microbial attack and the necessity to develop immunological memory (Matsunaga and Rahman, [@B27]). While this may be true for the emergence of some features of the adaptive immune system, this view may not apply to many other components of the immune system. First, it does not take into account that the vast majority of interactions that occur between the microbiota and the mammalian immune system involve non-pathogenic bacteria. More importantly, commensals, as opposed to pathogens, do not limit the host's lifespan, reproducibility, and consequent vertical gene transfer, and actually probably enhance it. Thus, it is more likely that commensal microorganisms pose a stronger evolutionary pressure on the host's immune system than pathogens, a view that we share with others (McFall-Ngai, [@B30]; Lee and Mazmanian, [@B24]).

The goal of this minireview is to describe some of the diverse mechanisms of commensal--host communication in the mammalian intestine and to explore the effect that these have in immune homeostasis within the intestine and systemically.

Immune Consequences of an Axenic Life
=====================================

The generation of germ-free mice has given us great insight into the immune effects of a microbe-free life, the development of the immune system during early microbial colonization, and the effects of specific bacterial groups and species on the local and systemic immune system.

The immune system is poorly developed in the absence of microbes. Structurally, the aggregated lymphoid structures of the GALT: mesenteric lymph nodes (MLNs), isolated lymphoid follicles, cryptopatches, and Peyer's patches are all underdeveloped in germ-free mice (Mazmanian et al., [@B28]; Bouskra et al., [@B8]). These mice exhibit decreased amounts of most cytokines, CD4+ T helper cells, FoxP3+ Tregs, B cells, Th17 cells, IgA, antimicrobial peptides, MHC class II, etc. (Moreau et al., [@B31]; Dobber et al., [@B11]; Strauch et al., [@B44]; Ivanov et al., [@B21]; Niess et al., [@B33]; Gaboriau-Routhiau et al., [@B15]; Round and Mazmanian, [@B38]), and inoculating them with a single species of bacteria can revert many of these defects (Umesaki et al., [@B49]; Mazmanian et al., [@B28]). Gut bacteria also have critical effects on the development of intestinal epithelial cells (IECs). IECs are the first cells to encounter the microbiota and are able to integrate most microbial signals and dictate the tone of the immune response of the underlying lamina propria immune cells (Rescigno, [@B37]). IECs express microbial pattern recognition receptors (PRR) that bind to microbial signals and upregulate the expression of mucus, cytokines, and other immune components (Rescigno, [@B37]). In the absence of bacteria, not only do these cells have a low expression of PRRs (Willing and Van Kessel, [@B55]), they also fail to develop their typical microvilli pattern and show a slow cell turnover rate (Abrams et al., [@B1]).

Not surprisingly, the functionality of the immune system in axenic mice is very poor as well. Germ-free and even mono-colonized mice do not develop oral tolerance (Rask et al., [@B36]). Germ-free mice and antibiotic-treated mice are significantly more susceptible to infectious disease from several intestinal pathogens, including *Shigella flexneri* (Sprinz et al., [@B43]), *Citrobacter rodentium* (Wlodarska et al., [@B56]), *Listeria monocytogenes* (Zachar and Savage, [@B59]), and *Salmonella typhimurium* (Nardi et al., [@B32]; Sekirov et al., [@B40]; Ferreira et al., [@B14]). The microbiota can prevent or ameliorate infection by direct microbial antagonism or by indirectly promoting appropriate host immune defenses. Direct microbial effects, also defined as "colonization resistance" (van der Waaij et al., [@B50]), include host receptor and nutrient competition, and secretion of antimicrobial substances (Sekirov and Finlay, [@B39]). The importance of these effects were demonstrated in a study where transfer of a normal microflora, in the absence of T and B cells, cleared infection with *S. typhimurium* (Endt et al., [@B13]). This study highlights the importance of the competitive pressures exerted by the microbiota as well as the role of the innate immune response in enteric infections. In another study, a fecal transplant from a mouse strain resistant to *C. rodentium* was sufficient to delay pathogen colonization and reduce mortality in a mouse strain lethally susceptible to infection. In addition, antibiotic therapy increased disease severity in resistance mice, suggesting that the difference in infection susceptibility between the two mice strains can be explained, at least in part, by differences in microbiota composition (Willing et al., [@B54]).

A normal microbiota has also been shown to help clear pathogens by stimulating several host immune effectors. In one study, oral treatment with peptidoglycan from the intestinal microbiota was effective in preventing pneumococcal sepsis in mice. Levels of this bacterial membrane component in serum correlated with systemic neutrophil killing capacity and activation of the innate immune receptor NOD1, indicating that signals from the microbiota translocate across the intestinal barrier and interact with systemic immune cells (Clarke et al., [@B10]). Another example of how microbial-derived signals regulate the systemic immune response comes from a study that showed that administration of the TLR5 ligand, flagellin, to antibiotic-treated mice inhibited colonization with vancomycin resistant *Enterococcus* (VRE). Intraperitoneal injection of flagellin upregulated the expression of the bactericidal lectin REGIIIγ in IECs and Paneth cells in the small intestine via activation of TLR5 in hematopoietic cells and secretion of IL-22 (Kinnebrew et al., [@B22]). Flagellin stimulation has also been shown to induce differentiation of non-specific IgA+ plasma cells via activation of TLR5 in intestinal dendritic cells (Uematsu et al., [@B48]). Colonization with the microorganism *Bacteroides fragilis* is sufficient to prevent murine experimental colitis induced by *Helicobacter hepaticus*. *B. fragilis* is coated with polysaccharide A (PSA) and this capsular component was shown to suppress IL-17, increase IL-10 production and ameliorate disease in this model (Mazmanian et al., [@B29]).

The Commensal Microbiota Balances Pro and Anti-Inflammatory Immune Mechanisms
=============================================================================

The Th17 immune response provides a good example of how the microbiota mediates the balance between immune homeostasis and uncontrolled inflammation. Overproduction of Th17 cytokines IL-17 and IL-23 is associated with colitis (Atarashi et al., [@B5]; Buonocore et al., [@B9]) and autoimmunity (Wen et al., [@B51]; Lee et al., [@B25]; Wu et al., [@B58]); however, Th17 cells are critical in controlling extracellular bacterial and fungal infections (Smith et al., [@B41]; Wu et al., [@B58]). Induction of Th17 immunity is crucial to prevent infection with *C. rodentium*, a murine pathogen that induces similar inflammation to enteropathogenic *E. coli* in humans (Wu et al., [@B58]). Thus, the right intensity of Th17 response must be achieved in order to prevent microbial attack and avoid uncontrolled inflammation. Segmented filamentous bacteria (SFB) are an unclassified species that resides in the murine ileum and has been shown to be a potent stimulator of the Th17 response (Gaboriau-Routhiau et al., [@B15]; Wu et al., [@B58]). Colonization with SFB induced the upregulation of cytokines, antimicrobial peptides, and serum amyloid A (SAA), an acute phase protein secreted during inflammation. SAA is believed to promote the Th17 differentiation of CD4+ T cells (Ivanov et al., [@B20]; Ather et al., [@B6]). Another mechanism that leads to Th17 differentiation is the production of commensal-derived adenosine 5′ triphosphate (ATP). ATP in the lamina propria stimulates dendritic cells to produce IL-6 and TGF-β, two cytokines necessary for Th17 cell expansion (Atarashi et al., [@B5]). Not surprisingly, microbial signals are also involved in limiting the Th17 immune response. IECs produce IL-25, which inhibits IL-23 production and prevents Th17 differentiation in response to the commensal flora (Zaph et al., [@B60]). In addition, oral administration of purified PSA from *B. fragilis* downregulated the Th17 response and induced propagation of Tregs in mice that develop autoimmune encephalomyelitis. This treatment was sufficient to prevent disease in this animal model (Ochoa-Reparaz et al., [@B34]). Collectively, these findings show how the microbiota produces inflammatory and tolerogenic signals in order to achieve immune homeostasis, a state that is favorable for both the microbiota and the host.

It is still unknown how certain microbes induce a pro-inflammatory response and others a tolerogenic one, but due to the central role that Treg cells have in regulating inflammatory responses (Figure [1](#F1){ref-type="fig"}), one could speculate that microbes manipulate the Treg cell response as a strategy to regulate immune responses towards them. But how do Treg cells perform such task? These cells are selected in the thymus for their ability to suppress T cells with a high affinity to self-MHC molecules, thus preventing autoimmune responses, but it is still unknown how these cells differentiate between pathogens or commensal pathogen signals. One explanation may be that the antigens from the commensal microbiota are used to train naïve T cells to differentiate into Treg cells. A recent study provides evidence that this may in fact occur. Analysis of several repertoires of T cell receptor (TCR) α chain revealed that the TCRs from FoxP3+ Treg cells within the colonic lamina propria are highly heterogeneous compared to Treg cells from effector/memory T cells in the lamina propria and from Treg cells from secondary lymphoid organs. Moreover, the study showed that the mouse microbiota was essential for the induction of this particular population of colonic Treg cells from naïve T cells, implying that there may be post-thymic mechanisms of immune cell education that occur peripherally via interactions with the commensal microbiota (Lathrop et al., [@B23]). This implies that the immune system may have evolved to rely on the microbiota to complete the training of a specific population of immune cells.

![**The microbiota helps to maintain immune homeostasis by stimulating different arms of the T cell response**. **(A)** SFB is a potent inducer of Th17 cells, whereas pathogens like *S. typhimurium* induce an effector Th1 response. PSA from *B. fragilis* stimulates the differentiation of FoxP3+ T cells, which downregulate the pro-inflammatory Th1 and Th17 responses. **(B)** Different environmental and host-derived factors are known to cause dysbiosis. Imbalances in the intestinal microbiota can favor Th17 pro-inflammatory T cells over regulatory FoxP3+ T cells, inducing inflammatory response that can damage the intestinal epithelium. In a genetically predisposed host this can lead to chronic inflammatory disease, such as IBD or autoimmunity.](fimmu-03-00033-g001){#F1}

Dissecting the Gut Microbiota
=============================

Although our knowledge of the immune effects caused by the microbiota is growing, much less is known about what constitutes a normal microbiota and which groups of microorganisms are beneficial or detrimental to immune homeostasis. Sequencing-based studies have substantially increased our knowledge of the ecology of the mammalian intestine, although it is safe to assume that we are likely at the early stages of comprehending this complex population.

Analyses of the human gut microbiota have yielded several important findings. First, although there is great inter-individual variability at the species level, there appears to be low variability between individuals at the phylum level (Eckburg et al., [@B12]; Turnbaugh et al., [@B47]). The human gut is colonized by mainly three phyla: Firmicutes, Bacteroidetes, and Actinobacteria. The most predominant bacterial families are Ruminococcaceae, Lachnospiraceae, Eubacteriaceae, and Bacteroidaceae, in what has been defined as the "core members of the microbiota" (Tap et al., [@B46]). Genetics and environmental factors, such as birth delivery method, diet, and antibiotic use have an important role in establishing the composition of the microbiota (Ley et al., [@B26]; Penders et al., [@B35]; Adlerberth, [@B2]; Benson et al., [@B7]; Willing et al., [@B53]). Compositional studies have also shown that certain members of the flora may be indicative of disease states. For example, the bacterium *Faecalibacterium prausnitzii*, a member of the Ruminococcaceae family is absent in samples from Crohn's disease (CD) patients (Sokol et al., [@B42]; Willing et al., [@B52]). Moreover, amelioration of disease with the anti TNF antibody, infliximab, allows *F. prausnitzii* to recolonize (Swidsinski et al., [@B45]). Furthermore, *F. prausnitzii* levels do not change in patients with ulcerative colitis, a disease characterized by Th2-type inflammation, suggesting that this microorganism is particularly susceptible to Th1 (predominant in CD) and not Th2-type inflammation.

A recent study analyzed the human fecal microbiota of 39 individuals from 6 different developed countries and found that there are three distinct ecosystems in the human gut, or "enterotypes." The genus *Bacteroides* is highly abundant in enterotype 1, *Prevotella* is very common for enterotype type 2 and *Ruminococcus* in enterotype 3. Although the functional implications of all enterotypes are still under study, it seems that each enterotype favors the synthesis of certain metabolic products. Enterotype 1 ecosystem favors the production of enzymes involved in biotin synthesis, whereas enterotype 2 species produce more enzymes for thiamine synthesis (Arumugam et al., [@B4]). Another study examined the fecal microbiota of 98 individuals and showed that samples clustered into two of the previously described enterotypes: *Bacteroides*-rich and *Prevotella*-rich ecosystems. Interestingly, the authors were able to correlate these enterotypes with long-term diets. Individuals with high animal fat in their diet clustered in the *Bacteroides* enterotype, whereas diets high in carbohydrate clustered in the *Prevotella* enterotype. A short-term intervention with a carbohydrate-rich diet did not cause a switch from *Bacteroides* into *Prevotella* enterotypes, suggesting that they reflect long-term diet conditions (Wu et al., [@B57]). There are still many unanswered questions regarding the correlation between intestinal enterotypes and the immune status of the host, as well as the possibility that there are more than three enterotypes or subenterotypes. However, the compositional classification of the human gut microbiota into functional ecosystems has enormous potential as a marker of disease and as a treatment.

Final Remarks
=============

The immune environment of the gut is characterized by tolerance. To achieve this state, host immune cells must learn to exhibit a tolerogenic behavior toward most microbial antigens. Thus, besides protecting the host from microbial attack, post-natal bacterial colonization likely serves the immune system with another important function: to be used as the second "training ground" for some naïve immune cells. Although this view poses a caveat to the traditional view of the main function of immune system -- to distinguish between self and non-self -- it may explain why the majority of the bacterial antigens in the gut are perceived as self-antigens.

More mechanisms on how and what components of the commensal microbiota affect mucosal and systemic immunity will undoubtedly continue to be found. This will not only expand our view of our microbiota as an integral part of our bodies (Gill et al., [@B17]), but it also opens the real possibility of manipulating specific functions of the microbiota to tune immune defects that cause infectious, inflammatory, or autoimmune disease. Learning from the strategies that the microbiota use to balance the different arms of the immune response and using them to overcome disease may prove to be more efficient than modifying the immune imbalances that originate from defective genes and microbial dysbiosis.
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